Find your dream job now!

Click on Location links to filter by Job Title & Location.
Click on Company links to filter by Company & Location.
For exact match, enclose search terms in "double quotes".

Keywords: ICON, Location: Seoul

Page: 1

Clinical Trial Manager (PMS/IIT)

or related discipline At least 2~3 years of PM with Medical affairs studies (RMP, PMS, and IIS) Home-Based What ICON can... performance and nurtures talent. In addition to your competitive salary, ICON offers a range of additional benefits...

Company: ICON
Location: Seoul
Posted Date: 24 Dec 2024

Study Start Up Associate II

What ICON can offer you: Our success depends on the quality of our people. That’s why we’ve made it a priority to build... a diverse culture that rewards high performance and nurtures talent. In addition to your competitive salary, ICON offers...

Company: ICON
Location: Seoul
Posted Date: 12 Dec 2024

Korea Client Services Associate

Korea Clinical Services Associate ICON plc is a world-leading healthcare intelligence and clinical research... I to join our diverse and dynamic team. As a Client Service Associate I at ICON, you will play a pivotal role in delivering exceptional...

Company: ICON
Location: Seoul
Posted Date: 07 Dec 2024

Korea Pharma Solutions Clinical Research Associate I/II

Korea Pharma Solutions Clinical Research Associate I/II ICON plc is a world-leading healthcare intelligence... to join our diverse and dynamic team. As a Clinical Research Associate I/II at ICON, you will play a pivotal role in monitoring clinical...

Company: ICON
Location: Seoul
Posted Date: 06 Dec 2024

(Sr.) Regulatory Affairs Specialist

literacy skills, comfortable working with database GMP 서류 평가 진행하신 경험 있으신 분 Why ICON? At ICON, we embrace new perspectives... development. At ICON, our focus is to provide you with a comprehensive and competitive total reward package that comprises...

Company: ICON
Location: Seoul
Posted Date: 04 Dec 2024

(Sr.) CRA II

On-Site Global studies with oncology Home-Based What ICON can offer you: Our success depends on the quality.... In addition to your competitive salary, ICON offers a range of additional benefits. Our benefits are designed to be competitive...

Company: ICON
Location: Seoul
Posted Date: 01 Dec 2024

Sr. Clinical Investigator Payment Associate

research or pharmaceutical industry What ICON can offer you: Our success depends on the quality of our people... to your competitive salary, ICON offers a range of additional benefits. Our benefits are designed to be competitive within each country...

Company: ICON
Location: Seoul
Posted Date: 23 Nov 2024

Korea Biotech Solutions Clinical Research Associate I/II/Sr

Korea Biotech Solutions Clinical Research Associate I/II/Sr. ICON plc is a world-leading healthcare intelligence.... to join our diverse and dynamic team. As a Clinical Research Associate I/II/Sr. at ICON, you will play a pivotal role in monitoring...

Company: ICON
Location: Seoul
Posted Date: 13 Nov 2024

Senior CRA

in global oncology studies Home-Based What ICON can offer you: Our success depends on the quality of our people... to your competitive salary, ICON offers a range of additional benefits. Our benefits are designed to be competitive within each country...

Company: ICON
Location: Seoul
Posted Date: 30 Oct 2024

Clinical Research Associate I/II

Korea Pharma Solutions Clinical Research Associate I/II ICON plc is a world-leading healthcare intelligence..., and we welcome you to join us on our mission to shape the future of clinical development CRA II - Korea, Seoul ICON plc is a world-leading healthcare...

Company: ICON
Location: Seoul
Posted Date: 14 Oct 2024

Key Account Executive-CVS

the Careers icon on the Workday portal. For best results, use Google Chrome to view this page. Quote from Hiring...

Company: Brown-Forman
Location: Seoul
Posted Date: 09 Nov 2024

Marketing Science Partner, Korea

, and more. Already have a Career Profile? Marketing Science Partner, Korea Marketing Science Partner, Korea Location pin icon Seoul, South...

Company: Meta
Location: Seoul
Posted Date: 11 Oct 2024